Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

Texas Announces Audit for Topical Analgesics

The DWC will work with system participants to develop the audit plan, including timeframe, size, and case selection.
Read More →
May 4, 2026

Maryland Eases Requirements for Cardiovascular Presumption

Two separate bills would respectively change certain rules for firefighters and specific correctional officers.
Read More →
May 4, 2026

Arizona Considers Expanding Cancer Presumption for First Responders

The bill would add five years of retroactive effect, allowing certain individuals who were denied claims to file once more.
Read More →
May 4, 2026

Louisiana Bills to Watch

Three in-progress bills impact medical reimbursement and fee schedules, prescription drug authorizations, and medical necessity evaluations.
Read More →
May 4, 2026

WCRI Publishes CompScope Benchmarks

Claim costs increased 6% per year from 2022-2025 in the median study state, with state-level variations.
Read More →
May 4, 2026

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.
Read More →
April 27, 2026

Minnesota Publishes Drug Price Transparency Report

Prescription drug list prices increased 23% in the last year, far outpacing inflation.
Read More →
April 27, 2026

New York Could Exclude Unpaid Interns from Workers’ Comp

Such interns would not be considered employees, meaning they would not be entitled to various employee benefits.
Read More →
April 27, 2026

Oklahoma Employers Can Terminate Employees for Any Marijuana Use

Positive drug tests, even for medical use, can result in termination. The bill also updates rules around safety sensitive positions.
Read More →
April 27, 2026

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Expert Q&A: What Utah’s AI Prescription Renewal Pilot Signals About the Evolving Role of AI in Treatment Decisions

Utah’s prescription renewal pilot is a groundbreaking use case for AI in healthcare. What are the potential benefits and pitfalls?
Read More

The Cost of Exposure: How Occupational Cancer Impacts Workers’ Compensation

The risk and impact of occupational cancers vary significantly depending on the nature of the exposure and the affected workforce.
Read More

Utah Launches AI Prescription Renewal Pilot Program for Chronic Conditions

The pilot can approve a limited set of 192 medications and will be broken into three stages, each with different levels of review.
Read More

States Seek to Limit AI-Generated Care Decisions, Despite White House Order

Legislators continue to introduce bills to limit AI-generated healthcare decisions, even as the U.S. Attorney General has been instructed to oppose them.
Read More

White House Issues Executive Order to Reschedule Marijuana

Rescheduling marijuana to Schedule III will allow for greater clinical research, possible FDA-approved drugs, and more.
Read More

States Consider Expanding Presumptions

So far in 2026, eight states and counting are seeking to expand existing presumptions or create new presumptions.
Read More
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle